UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

     |X| Quarterly Report Pursuant To Section 13 or 15(d) of the Securities
                              Exchange Act Of 1934

                  For the quarterly period ended March 31, 2015

   |_| Transition Report Under Section 13 or 15(d) of the Securities Exchange
                                   Act Of 1934

             For the transition period from __________ to __________

                        Commission File Number: 000-54231

                                 AMERICANN, INC
                 ---------------------------------------------
             (Exact name of registrant as specified in its charter)

           DELAWARE                                      27-4336843
  ------------------------------              -------------------------------
(State or other jurisdiction                (I.R.S. Employer Identification No.)
 of incorporation or organization)

                          3200 Brighton Blvd. Unit 114
                                Denver, CO 80216
                  -------------------------------------------
          (Address of principal executive offices, including Zip Code)

        (303) 862-9000 (Issuer's telephone number, including area code)

                          -----------------------------
          (Former name or former address if changed since last report)

Check  whether the issuer (1) filed all reports  required to be filed by section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted  electronically  and
posted on its corporate Web site, if any, every  Interactive  Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter)  during the  preceding 12 months (or for such shorter  period that
the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a small reporting  company.  See
the   definitions   of   "large   accelerated   filer,"   "accelerated   filer,"
"non-accelerated  filer," and "smaller  reporting  company" in Rule 12b-2 of the
Exchange Act.

Large accelerated filer  [ ]          Accelerated filer              [ ]
Non-accelerated filer    [ ]          Smaller reporting company      [x]

Indicate by check mark whether the  registrant  is a shell company (as defined
in Rule 12b-2 of the Exchange Act).     Yes [ ]     No [x]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:  16,631,000 shares of common stock as
of June 10, 2015.

<PAGE>

                                     Part II


                          Item 1. Financial Statements


                          Interim Financial Statements
                       for the period ended March 31, 2015
                                   (Unaudited)




                                       2
<PAGE>


 AmeriCann, Inc.
 (fka Nevada Health Scan, Inc.)
 Condensed Balance Sheet

                                                  Unaudited           Audited
                                                  March 31,       September  30,
 ASSETS                                             2015               2014

 Current Assets:
   Cash                                   $                -   $     173,956
   Interest receivable                                 16,386              -
   Deposits                                           100,000        100,000
   Prepaid expenses                                    58,333          5,000
   Land held for resale                             2,250,809      2,250,809
                                                -------------   ------------

      Total Current Assets                          2,425,528      2,529,765
                                            -----------------     ----------

 Plant, property, and equipment:
   Furniture and equipment (net of
   $896 and $394- depreciation)                         6,961          7,463

 Other assets:

   Notes receivable - Natures Own                     965,000      1,000,000
   Note and accounts receivable WGP                 1,037,341              -
   Deposit on web site development                     25,000              -
   Deferred financing costs                            27,772              -
    Security deposit                                    3,110          3,110
                                              --------------- --------------
      Total other assets                            2,058,223      1,003,110
                                                 ------------   ------------

            TOTAL ASSETS                          $ 4,490,712    $ 3,540,338
                                                  ===========    ===========

 LIABILITIES AND SHAREHOLDERS' EQUITY

 Current Liabilities:
   Accounts payable                             $      66,570  $      25,515
   Bank overdraft                                      11,259              -
   Related party payables                               5,500         16,357
   Interest payable - related party                     8,569          5,192
   Interest payable                                     3,033              -
   Other payables                                       8,181         12,981
   Deferred revenue                                         -         11,740
                                                                           -
   Note payable                                       650,000              -
                                                     --------       --------

      Total current liabilities                       753,112         71,785
                                                      -------       --------

 Long-term liabilities
   Note payable related party                       1,408,000        825,000
                                                    ---------       --------
      Total long-term liabilities                   1,408,000        825,000
                                                    ---------       --------

            TOTAL LIABILITIES                       2,161,112        896,785
                                                    ---------       --------

 SHAREHOLDERS' EQUITY

   Preferred stock, $0.0001 par value
   per share; Authorized 20,000,000
   Shares; Issued and outstanding
   -0- shares.                                              -              -
  Common Stock, $0.0001 per share;
   Authorized 100,000,000 Shares;
   Issued and outstanding 16,631,000
   and 16,581,000 at March 31, 2015
   and September 30, 2014 respectively                  1,663          1,658
   Capital paid in excess of par value              4,912,352      4,606,718
   Accumulated (Deficit)                           (2,584,415)    (1,964,823)
                                                 ------------     -----------
            TOTAL SHAREHOLDERS' EQUITY              2,329,600      2,643,553
                                                -------------    ------------

 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY        $4,490,712     $3,540,338
                                                   ==========     ==========


    See Accompanying Notes To These Unaudited Condensed Financial Statements.

                                       3
<PAGE>


 AmeriCann, Inc.
 (fka Nevada Health Scan, Inc.)
 Unaudited Condensed Statement Of Operations

<TABLE>
<S>                                             <C>          <C>           <C>             <C>

                                             Unaudited     Unaudited     Unaudited      Unaudited
                                             3 Months      3 Months      6 Months       6 Months
                                              Ended         Ended         Ended          Ended
                                             March 31,     March 31,     March 31,      March 31,
                                               2015          2014          2015           2014
                                             ---------     --------      ---------      ---------
 Revenue:
       Consulting                            $ 50,000      $     -       $ 80,000       $      -
       Interest                                54,595            -         99,801              -
                                               ------            -         ------              -

 Total revenue                                104,595            -        179,801              -


General & Administrative Expenses
   Accounting                                   5,250        3,750         15,250          8,650
   Advertising                                  3,200            -          6,075              -
   Contract and consulting                    115,590       34,140        178,774         34,140
   Depreciation                                   281            -            502              -
   Other G & A                                 43,604       21,463         89,032         21,663
   Legal                                       82,988       71,950        101,368         71,950
   Rent                                         8,560            -         16,870              -
   Salaries                                    39,000            -         69,518              -
   Stock based compensation                   159,522            -        272,306              -
   Stock Transfer Fee                           1,869          799          2,546          1,399
   Taxes                                        3,474            -         12,938              -
   Travel                                       4,615        5,347         10,120          5,347
                                             --------     --------       --------       --------
      Total G & A                             467,953      137,449        775,299        143,149
                                             --------     --------       --------       --------

 (Loss) from operations                      (363,358)    (137,449)      (595,498)      (143,149)
                                             ---------    ---------      ---------      ---------

 Other (expense)
   Interest expense                            (3,033)           -         (3,033)             -
   Interest expense - related party           (11,199)           -        (21,061)             -
                                             ---------   ---------       ---------      --------
      Total other income                      (14,232)           -        (24,094)             -
                                             ---------   ---------       --------       --------
            Net (loss)                    $  (377,590)  $ (137,449)    $ (619,592)    $ (143,149)
                                          ============  ===========    ===========    ===========

 Basic and diluted (Loss) per
   common share                           $     (0.02)  $    (0.01)    $    (0.04)    $    (0.01)
                                          ============  ===========    ===========    ===========

 Weighted Average Common Shares
   Outstanding                             16,603,222   15,625,222     16,591,989     15,865,220
                                          ============  ===========    ===========    ===========

    See Accompanying Notes To These Unaudited Condensed Financial Statements.

</TABLE>

                                       4
<PAGE>



 AmeriCann, Inc.
 (fka Nevada Health Scan, Inc.)
 Unaudited Statement of Cash Flows

                                                Unaudited         Unaudited
                                                6 Months          6 Months
                                                  Ended             Ended
                                                March 31,          March 31,
                                                   2015              2014
                                                ---------         ----------
 Cash Flows From Operating Activities:
   Net (Loss)                                  $ (619,592)       $ (143,149)

 Adjustments to reconcile net loss to net
   cash used in operating activities:
   Depreciation                                       502                 -
   Stock based compensation & option expense      272,306                 -
   Increase in interest receivable                (16,386)                -
   Increase in deposit and prepaid expenses       (20,000)          (30,000)
   Increase in Accounts Payable                    41,055             5,849
   Increase in bank overdraft                      11,259
   (Decrease) in related party payables           (10,857)
   Increase in interest payable                     3,033
   Increase in interest payable - related party     3,377
   Increase in other payables                       6,422
    (Decrease) in deferred revenue                (11,740)                -
                                                ----------        ----------
Net Cash Flows (used) in operations             (-340,621)         (167,300)
                                                ----------        ----------
Cash Flows from Investing Activities:

   Website development                            (25,000)                -
   Deposit on land                               (100,000)
   Advances made for note receivable - WGP       (937,341)                -
   Payment on note receivable                      35,000                 -
                                                ----------        ----------

 Net Cash Flows (used) in Investing
   activities                                  (1,027,341)                -

 Cash Flows from Financing Activities:
   Common stock issued for cash                         -           734,000
   Proceeds from note payable                     611,006                 -
   Proceeds from note payable - related party     790,000             5,600
   Payments on note payable - related party      (207,000)                -
                                                ----------        ----------

      Net Cash Flows provided by
        financing activities                    1,194,006           739,600
                                               -----------        ----------

 Net Increase (Decrease) In Cash and
   cash equivalents                              (173,956)          572,300
 Cash and cash equivalents at beginning
   of period                                      173,956                 -
                                               -----------        ----------
 Cash and cash equivalents at end of period    $        0        $  572,300
                                               ===========       ===========

 Supplementary Disclosure of Cash Flow
   Information:

 Cash paid for interest                        $   17,684        $        -
                                               ===========       ===========
 Cash paid for income taxes                    $        -        $        -
                                               ===========       ===========
 Expenses paid on behalf of Company            $   37,720        $        -
                                               ===========       ===========
 Deposit used for loan advances                $  100,000        $        -
                                               ===========       ===========
 Deferred financing costs                      $   27,772        $        -
                                               ===========       ===========
 Accrued liabilities paid directly to lender   $   11,222        $        -
                                               ===========       ===========
 Shares issued for prepaid services            $   50,000        $        -
                                               ===========       ===========

    See Accompanying Notes To These Unaudited Condensed Financial Statements.

                                       5
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 1.  DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

AmeriCann,  Inc. (fka Nevada Health Scan,  Inc.) ("the Company" or "the Issuer")
was  organized  under the laws of the State of  Delaware on June 25,  2010.  The
Company was established as part of the Chapter 11 reorganization of AP Corporate
Services,  Inc. ("AP").  Under AP's Plan of Reorganization,  as confirmed by the
U.S.  Bankruptcy Court for the Central  District of California,  the Company was
incorporated  to:  (1)  receive  and  own  any  interest  which  AP  had  in the
development  of an MRI  scanning  facility;  and (2) issue  shares of its common
stock to AP's general unsecured creditors, to its administrative  creditors, and
to its shareholders.

Since the Company lacked the resources to  effectively  develop an MRI facility,
in June 2012 the  Company  decided  to  promote  medical  tourism  by  providing
information  on a website  for those  seeking to travel  abroad  for  healthcare
services.  The Company  planned to generate  revenue by selling  advertising  to
healthcare   providers  and  related  businesses  including  hotels  and  travel
agencies.

In September 2013, the Company abandoned its business plan relating to promoting
medical tourism.

On January 17,  2014,  a  privately  held  limited  liability  company  acquired
approximately  93% of the  Company's  outstanding  shares of common  stock  from
several of the Company's  shareholders  which resulted in a change in control of
the Company.

The Company's new business plan is to offer a comprehensive,  turnkey package of
services  that  includes  consulting,  design,  construction  and  financing  to
approved and licensed  marijuana  operators  throughout the United  States.  The
Company's  business  plan is based on the  anticipated  growth of the  regulated
marijuana market in the United States.

                                       6
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 1.  DISCRIPTION   OF  BUSINESS  AND   SIGNIFICANT   ACCOUNTING   POLICIES
         (Continued)

The Company's  activities  are subject to  significant  risks and  uncertainties
including failure to secure funding to properly grow the operations.

Basis of Presentation

The following (a)  condensed  balance sheet as of September 30, 2014,  which has
been derived from audited financial statements,  and (b) the unaudited condensed
financial  statements  as of March 31,  2015 and 2014,  have  been  prepared  in
accordance with accounting principles generally accepted in the United States of
America and the rules of the Securities  and Exchange  Commission  ("SEC"),  and
should be read in conjunction  with the audited  financial  statements and notes
thereto  contained in the Company's Form 10-K filed with the SEC on February 18,
2015.  In the  opinion of  management,  all  adjustments,  consisting  of normal
recurring  adjustments,  necessary for a fair presentation of financial position
and the  results of  operations  for the  interim  periods  presented  have been
reflected  herein.  The  results  of  operations  for  interim  periods  are not
necessarily  indicative of the results to be expected for future quarters or for
the full year. Notes to the condensed  financial  statements which substantially
duplicate  the  disclosure  contained in the audited  financial  statements  for
fiscal 2014 as reported in the Form 10-K have been omitted.

Summary of Significant Accounting Policies

This  summary of  significant  accounting  policies is  presented  to assist the
reader in understanding and evaluating the Company's financial  statements.  The
condensed consolidated financial statements and notes are representations of the
Company's management,  which is responsible for their integrity and objectivity.
These accounting  policies conform to generally accepted  accounting  principles
and  have  been  consistently  applied  in  the  preparation  of  the  financial
statements.

                                       7
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

     A. USE OF ESTIMATES


The  preparation  of financial  statements  in  conformity  with U.S.  generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that  affect the  reported  amounts of assets and  liabilities  and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting  period.  The  more  significant  estimates  and  assumptions  made by
management  are valuation of equity  instruments,  depreciation  of property and
equipment,  and deferred tax asset  valuation.  Actual results could differ from
those estimates as the current economic  environment has increased the degree of
uncertainty  inherent  in these  estimates  and  assumptions.

     B. CASH AND CASH EQUIVALENTS

Cash and cash  equivalents  includes cash on hand,  demand deposit  accounts and
temporary cash investments with maturities of ninety days or less at the date of
purchase.

     C. PROPERTY AND EQUIPMENT


LONG-LIVED ASSETS

The  Company's  long-lived  assets  consisted of property and  equipment and are
reviewed for  impairment in  accordance  with the guidance of the FASB Topic ASC
360,  Property,  Plant, and Equipment,  and FASB ASC Topic 205,  Presentation of
Financial  Statements.  The Company  tests for  impairment  losses on long-lived
assets used in operations  whenever events or changes in circumstances  indicate
that the carrying amount of the asset may not be recoverable.  Recoverability of
an asset to be held and used is measured by a comparison of the carrying  amount
of an asset to the future  undiscounted  cash flows  expected to be generated by
the asset.  If such asset is  considered  to be impaired,  the  impairment to be
recognized  is measured by the amount by which the carrying  amount of the asset
exceeds its fair value. Impairment evaluations involve management's estimates on
asset  useful  lives and future cash flows.  Actual  useful lives and cash flows
could be  different  from  those  estimated  by  management  which  could have a
material effect on our reporting results and financial positions.  Fair value is
determined through various valuation  techniques  including discounted cash flow
models,  quoted  market  values  and  third-party  independent  appraisals,   as
considered necessary. Through December 31, 2014, the Company had not experienced
impairment losses on its long-lived assets.  However, there can be no assurances
that demand for the Company's  products or services will  continue,  which could
result in an impairment of long-lived assets in the future.

Office furniture and equipment 7 years.

                                       8
<PAGE>


                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 1.  DISCRIPTION   OF  BUSINESS  AND   SIGNIFICANT   ACCOUNTING   POLICIES
         (Continued)

     D. DEPOSIT ON WEBSITE DEVELOPMENT

The  Company  recognized  the costs  associated  with  developing  a website  in
accordance with ASC 350-50 "Website  Development Cost". The website  development
costs are divided into three stages, planning,  development and production.  The
development  stage can further be classified as application  and  infrastructure
development,  graphics  development and content  development.  In short, website
development cost for internal use should be capitalized except content input and
data conversion costs in content  development  stage.  Costs associated with the
website consist of website  development costs paid to third parties. As of March
31, 2015 $33,000 was advanced as a deposit to the website  development  Company.
The company  completed  phase one and two which is the planning phase and $8,000
was written off as expense.

     E. DEFERRED FINANCING COSTS

Deferred  financing  costs  represent  costs  incurred  in the  connection  with
obtaining  debt  financing.  These  costs are  amortized  ratably and charged to
financing expenses over the term of the related debt.

     F. RELATED PARTIES

A party is  considered  to be related to the  Company if the party  directly  or
indirectly or through one or more intermediaries, controls, is controlled by, or
is under common control with the Company. Related parties also include principal
owners of the Company,  its  management,  members of the  immediate  families of
principal  owners of the Company and its management and other parties with which
the Company may deal if one party  controls or can  significantly  influence the
management  or  operating  policies  of the other to an  extent  that one of the
transacting  parties  might be  prevented  from fully  pursuing its own separate
interests. A party which can significantly influence the management or operating
policies of the transacting parties or if it has an ownership interest in one of
the transacting  parties and can significantly  influence the other to an extent
that one or more of the  transacting  parties  might  be  prevented  from  fully
pursuing its own separate interests is also a related party.

                                       9
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 1.  DISCRIPTION   OF  BUSINESS  AND   SIGNIFICANT   ACCOUNTING   POLICIES
         (Continued)

     G. REVENUE RECOGNITION

The  Company  recognizes  revenue  on  consulting  at the  time the  service  is
rendered.

     H.  EQUITY  INSTRUMENTS  ISSUED TO  NON-EMPLOYEES  FOR  ACQUIRING  GOODS OR
SERVICES

Issuances  of the  Company's  common stock or warrants  for  acquiring  goods or
services  are  measured at the fair value of the  consideration  received or the
fair  value  of the  equity  instruments  issued,  whichever  is  more  reliably
measurable.  The measurement  date for the fair value of the equity  instruments
issued to consultants or vendors is determined at the earlier of (i) the date at
which a commitment for performance to earn the equity  instruments is reached (a
"performance  commitment"  which would  include a penalty  considered to be of a
magnitude that is a sufficiently large disincentive for  nonperformance) or (ii)
the  date at which  performance  is  complete.  When it is  appropriate  for the
Company  to  recognize  the cost of a  transaction  during  financial  reporting
periods prior to the  measurement  date,  for purposes of  recognition  of costs
during those periods, the equity instrument is measured at the then-current fair
values at each of those interim  financial  reporting dates. As a result,  stock
options  granted to consultants  are measured at the then current fair values at
each reporting date.

     I. LOSS PER SHARE

The Company  computes net loss per share in accordance  with the FASB Accounting
Standards Codification ("ASC"). The ASC specifies the computation,  presentation
and disclosure  requirements  for loss per share for entities with publicly held
common stock.

Basic  loss per  share  amounts  is  computed  by  dividing  the net loss by the
weighted  average number of common shares  outstanding.  The equity  instruments
such  as  warrants  and  options  were  not  included  in  the  loss  per  share
calculations because the inclusion would have been anti-dilutive.

                                       10
<PAGE>



                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

     J. CONCENTRATION OF CREDIT RISKS

Financial  instruments that potentially subject the Company to concentrations of
credit risk  consist  principally  of cash,  notes  receivables,  deposits,  and
accounts  receivables.  The  Company  places its cash with high  credit  quality
financial  institutions.  As of March 31, 2015 and September 30, 2014 there were
$20,000 and $-0- in trade  receivables,  which is included in notes and accounts
receivable WGP in the accompanying balance sheet.

     K. RECENT ACCOUNTING PRONOUNCEMENTS


The Company has reviewed all recently issued, but not yet effective,  accounting
pronouncements   and  does  not  believe   the  future   adoption  of  any  such
pronouncements  may be  expected  to cause a  material  impact on our  financial
condition or the results of its operations

NOTE 2.  GOING CONCERN

The accompanying  financial  statements have been prepared  assuming the Company
will continue as a going concern,  which  contemplates,  among other things, the
realization  of assets and  satisfaction  of liabilities in the normal course of
business. The Company had an accumulated deficit of approximately $2,584,000 and
$1,965,000  at March 31, 2015 and September  30, 2014,  respectively,  had a net
loss of approximately,  $620,000 for the six months period ended March 31, 2015.
These  matters,  among  others,  raise  substantial  doubt  about our ability to
continue  as a going  concern.  While the  Company  is  attempting  to  increase
operations and generate additional revenues, the Company's cash position may not
be  significant  enough to support the Company's  daily  operations.  Management
intends to raise additional funds by way of a public offering.

Management  believes that the actions presently being taken to further implement
its business plan and generate  additional  revenues provide the opportunity for
the Company to continue as a going  concern.  While the Company  believes in the
viability of its strategy to generate  additional revenues and in its ability to
raise additional funds,  there can be no assurances to that effect.  The ability
of the Company to continue as a going  concern is dependent  upon the  Company's
ability to further implement its business plan and generate additional revenues.

The financial  statements do not include any adjustments that might be necessary
if the Company is unable to continue as a going concern.

                                       11
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 3.  NOTES RECEIVABLE

Natures Own

On June 23, 2014 the Company  entered into a secured  financing  agreement  with
Nature's Own Wellness Center, Inc. ("Nature's Own"). Financing was provided in a
series of tranches for the  construction  progresses to renovate a 15,000 square
foot warehouse into a cannabis growing and processing facility. The total amount
of financing was $1,000,000,  and accrues interest at 18% per annum, and matures
on November  1, 2016.  Monthly  interest  only  payments  are $15,000 due July 1
through  December  1,  2014.   Monthly   principal  and  interest   payments  of
approximately  $50,000  begin on December  1, 2014  through  maturity.  The note
receivable is  collateralized by substantially all of the assets of Nature's Own
and is personally guaranteed by one of the majority owners of Nature's Own.

Effective  January 1, 2015 the Company and Natures Own Wellness  Center modified
the  loan  agreement  and  consulting   agreement   between  the  parties.   The
modification to the loan agreement  eliminated  required  principal payments for
January  through  May 2015 and  increased  the final  principal  payment  due on
December 1, 2016 to $182,531. The Company analyzed the modification to determine
if the change in terms was a troubled debt restructuring.  Based on ASC Subtopic
310-40,  Receivables - Troubled  Debt  Restructuring  by Creditors,  the Company
determined that a concession was not made.  Therefore the modification was not a
troubled debt restructuring. The consulting agreement was modified to extend the
term of the consulting agreement to May 31, 2017. Monthly consulting payments of
$10,000  remain the same.  Consulting  fees  earned for the three and six months
period ended March 31, 2015 were $30,000 and $60,000 respectively.

The balance of the note receivable as of March 31, 2015 and earned September 30,
2014 was $965,000 and $1,000,000 respectively. Accrued interest receivable as of
March 31, 2015 was  approximately  $16,000.  Interest income for the three month
period  and  six  month   period  ended  March  31,  2015  $43,234  and  $88,440
respectively.

Nature's Own is a licensed  Colorado  cannabis  dispensary owner and grower with
separate and distinct  operations.  Nature's Own has its own revenue  generating
activities and is not  financially  dependent upon the Company.  The Company has
not  guaranteed  any debtor or  obligation  of Nature's  Own. The Company has no
control  of  Nature's  Own  operations  and  does  not  perform  any  management
functions.  However, a majority  shareholder of Nature's Own owns 100,000 shares
of common stock of the Company.  The Company performed  analysis to determine if
Nature's Own is required to be consolidated under ASC 810,  Consolidations,  and
determined  that  the  Company  is not the  primary  beneficiary.  As a  result,
consolidation was not required.

                                       12
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 3.  NOTES RECEIVABLE (Continued)

WGP

On September 21, 2014 AmeriCann  entered into two loan  agreements with Wellness
Group Pharms, LLC ("WGP").  Subsequent to entering into the loan agreements WGP,
applied  to the  state  of  Illinois  for  licenses  to  operate  two  marijuana
cultivation  facilities under the Illinois Compassionate Use of Medical Cannabis
Pilot Program Act. As part of this agreement, AmeriCann, Inc. deposited $100,000
into a Trust  Account held by its  corporate  attorneys as deposits for two Loan
Agreements for applications in the Illinois medical  marijuana  program.  As per
the Loan Agreements,  AmeriCann, Inc. deposited $50,000 into a trust account for
each of the applications.

On February 2, 2015 WGP was notified that it was awarded one of the two licenses
for which it applied under the Illinois act.

On February 23, 2015 AmeriCann and WGP amended their  agreement and expanded the
scope of the agreement.

The amended  agreement  calls for  AmeriCann to serve as the  developer of a new
facility to be called the Illinois Medical  Cannabis Center ("IMCC").  WGP plans
to use the IMCC to cultivate, process and distribute medical cannabis to many of
the state's 52 newly licensed medical dispensaries.

AmeriCann  will  serve as the  project  developer  and will own the  IMCC,  plus
provide working capital funding and horticultural  assistance to WGP.  AmeriCann
will receive,  over a 12-year period, a 25% fee on all cannabis  produced at the
IMCC,  $240,000 annually in consulting fees and $6.00 per square foot in monthly
lease payments.

The working capital loan carries an annual interest rate of 18%. Interest on the
loan  initially  accrues and is added to the loan as  principal  until the first
calendar  month in which WGP commences  operations in the Facility.  The term of
the loan ends December 31, 2017.

                                       13
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 3.  NOTES RECEIVABLE (Continued)

WGP (continued)

AmeriCann  commenced  construction  of the IMCC in March  with a first  phase of
approximately  27,000 square feet.  WPG's initial  harvest is projected for late
Fall  2015.  AmeriCann  plans  to add  additional  cultivation  capacity  as the
Illinois Medical Cannabis Program develops.

Additionally,  AmeriCann has commenced  development  of  comprehensive  cannabis
infused product line. As a part of the amended agreement, AmeriCann will license
this proprietary  product brand to WGP. WGP, in turn, will process,  package and
distribute  infused  cannabis  products  to  licensed  medical  dispensaries  in
Illinois.  AmeriCann  will  receive a 20% royalty  from the sale of all cannabis
extractions and infused products.

On February 23rd,  2015 AmeriCann  provided  initial  funding of $600,000 to WGP
under  the  Working  Capital  Loan  Draw #1.  Funds  were  used for the  premium
($400,000) for a $2 million  performance  bond and for the payment of a $200,000
state  license fee. The $100,000  deposited  into the trust account on September
21, 2014 was used as part of the $600,000 payment made on February 23rd, 2015.

As part of the  second  draw of the  Working  Capital  Loan  from  the  Company,
AmeriCann provided an additional $73,924 during March to WGP for working capital
to pay consultants, lobbyists, and legal fees.

On April 7,  2015,  WGP sent  notice to  AmeriCann  claiming  that the  $214,522
payment that  AmeriCann made for the building was not authorized by WGP and that
AmeriCann's  payment for building was made "...at its own election." WGP further
claimed that AmeirCann  failed to provide funding  pursuant to the original plan
and as a result the agreements between AmeriCann and WGP were void.

On  April  10,  2015,  WGP  notified  AmeriCann  that the  relationship  between
AmeriCann and WGP could continue only if AmeriCann agreed to accept  significant
changes  to the  original  agreements.  In this  correspondence,  WGP made eight
demands including the following:

(1) That AmeriCann provide an extra $2,000,000 in working capital to WGP,

(2) That AmeriCann agree to reduce the interest rate on the working capital loan
to WGP by 6%, and

(3) That AmeriCann would not pay vendors and suppliers directly, but rather that
all funds had to be provided to WGP for  disbursements.

                                       14
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 3.  NOTES RECEIVABLE (Continued)

WGP (continued)

AmeriCann's  management  believed that WGP's notice to void the  agreements  was
without merit and that this was merely an attempt to renegotiate  the terms of a
valid contract. AmeriCann rejected WGP's proposal outright.

The Company has  notified  WGP that the Company has  fulfilled  its  obligations
pursuant  to its  agreements  with WGP but due to WGP's  anticipatory  breach of
contract,  and  repeated  lack of good  faith and fair  dealing,  the  Company's
agreements with WGP were terminated.

The Company has not filed any formal  litigation  but has provided  legal notice
that AmeriCann's loan in the amount to WGP are immediately due and payable.  The
funds deployed by AmeriCann are secured with a commercial promissory note and an
executed  Security  Agreement  covering  all funds loaned under the terms of the
agreements.As a result,  AmeriCann's loan in the amount of $673,294 plus accrued
interest and consulting fees to WGP are immediately due and payable;

The balance of the note  receivable as of March 31, 2015 was  $673,924.  Accrued
interest receivable for the year ended March 31, 2015 was approximately $12,000.
Both  amounts  were  included  in  notes  and  accounts  receivable  WPG  in the
accompanying, condensed balance sheet.Interest income for the three month period
and six month period ended March 31, 2015 was $11,690 and $11,690 respectively.

                                       15
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 3.  NOTES RECEIVABLE (Continued)

WGP (continued)

Property Improvements WGP

The Company funded $332,357  towards the  construction  of the Illinois  Medical
Cannabis Center (IMCC). The improvements to the property include the purchase of
a  $215,000  metal  building,  site work  including  excavation,  asphalt  road,
concrete  foundations  and soft costs for  architectural  drawings,  engineering
survey, builder supervision, general contractor FEE and a contingency account.

Combined  monies  advanced,  trade  receivables,  interest  receivable  and land
improvements paid on WGP's behalf totals $1,037,341, and was recognized as notes
and accounts receivable in the accompanying condensed balance sheet..

NOTE 4.   LAND HELD FOR RESALE

On July 31,  2014 the  Company  closed on an all cash  purchase  of a  five-acre
parcel of land located in north central  Denver,  Colorado.  The total  purchase
price for the property was approximately  $2,250,000.  The property is currently
zoned for cannabis  cultivation and processing by the City and County of Denver.
On May 5, 2015 the Company  entered into an agreement to sell the property to an
unrelated party for $2,500,000. The sale is scheduled to close July 3, 2015.

NOTE 5.    NOTES PAYABLE

On March 21, 2015  AmeriCann  closed on a $650,000 loan from a third party.  The
Note is due  September  21,  2015 and  secured  by the land held for  resale the
Company owns at 4200 Monaco Street,  Denver,  Colorado. The annual interest rate
for the loan is 14%.  The loan is  interest  only  until the  principal  and any
accrued  interest is due on September 21, 2015.  Interest  expense for the three
and six month period ended March 31, 2015 was $3,033.  As part of the  financing
the Company incurred $27,772 in deferred  financing costs that will be amortized
over the life of the loan.

                                       16
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015


NOTE 6.  EARNINGS PER SHARE

The following  table sets forth the  computation of basic and diluted net income
per share:

                                                            For the six months
                                                              Ended March 31,
                                                            ------------------
                                                            2015          2014
                                                            ----          ----
Net (loss) income attributable to common
   stockholders                                          $ (619,592) $ (143,149)
Basic weighted average outstanding shares of
   common stock                                          16,591,989  15,865,220
Dilutive affects of common share equivalents                    -0-         -0-
Dilutive weighted average outstanding shares
  of common stock                                        16,591,989  15,865,220
                                                         ==========  ==========

Net loss per share of voting and nonvoting common stock
 Basic and Diluted                                       $    (0.04) $    (0.01)


                                                           For the three months
                                                              Ended March 31,
                                                           --------------------
                                                           2015           2014
                                                           ----           ----

Net (loss) income attributable to common stockholders    $ (377,590) $ (137,449)
Basic weighted average outstanding shares of
   common stock                                          16,603,222  15,625,222
Dilutive affects of common share equivalents                    -0-         -0-
Dilutive weighted average outstanding shares
   of common stock                                       16,603,222  15,625,222
                                                         ==========  ==========

Net loss per share of voting and nonvoting
   common stock
 Basic and Diluted                                       $    (0.02) $    (0.01)
                                                         =========== ===========

                                       17
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 7.   INCOME TAXES

The Company did not record any income tax expense or benefit for the three month
or six month period ended March 31, 2015.  The Company  increased  its valuation
allowance  and  reduced  its net  deferred  tax  assets to zero.  The  Company's
assessment of the realization of its deferred tax assets has not changed, and as
a result the Company  continues to maintain a full  valuation  allowance for its
net deferred assets as of March 31, 2015.

As of March 31, 2015,  the Company did not have any  unrecognized  tax benefits.
There were no significant changes to the calculation since September 30, 2014.

NOTE 8.     STOCK BASED COMPENSATION

On March 25, 2014,  the Company  entered into an employment  agreement  with Mr.
Keogh. The agreement: (i) has an initial term of three years; (ii) requires that
Mr.  Keogh devote at least 50% of his time to the Company  and;  (iii)  provides
that the Company  will pay Mr.  Keogh  $12,000 per month  during the term of the
agreement.  Pursuant to the employment  agreement,  Strategic  Capital Partners,
LLC, the Company's largest  shareholder,  sold 1,200,000 shares of the Company's
common stock to Mr.  Keogh at a price of $0.001 per share.  The  estimated  fair
market  value of the  stock was $.75 per share  based the then  current  Private
Placement Memorandum in place resulting in an aggregate stock based compensation
of approximately  $900,000 for the difference  between the estimated fair market
value of $.75 and the purchase price of $.001 per share.  As the Company expects
the shares to be earned over the vesting  period,  the Company will amortize the
entire  amount  to  stock  based  compensation  in the  Company's  statement  of
operations over the vesting  period.  For the three month period ended March 31,
2015,  the Company has  amortized  approximately  $103,000 and $206,000 to stock
based   compensation.   Through  March  31,  2015,  the  Company  has  amortized
approximately $753,000.

NOTE 9.     EQUITY

On February  19,  2015 the  Company  issued  50,000  shares of common  stock for
investment relation services valued at $1.00 per share or $50,000. 25,000 shares
vest  immediately and 25,000 shares vest in a six month period.  As of March 31,
2015 there is $33,333 in the prepaid asset account. For the three and six months
period ended March 31, 2015,  $16,667 was amortized to stock based  compensation
expense.

                                       18
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015


NOTE 10.   RELATED PARTY TRANSACTIONS AND RELATED PARTY NOTES PAYABLE

During year ended  September  30, 2014,  the  President of the Company  advanced
approximately $16,000 to cover certain expenses.  This cash advance is evidenced
by a  non-interest  bearing note, is due on demand and is recorded under related
party payables in the accompanying  balance sheet.  The outstanding  balance was
approximately  $16,000 and $5,500 as of  September  30, 2014 and March 31, 2015,
respectively.

During the six months period ended March 31, 2015, the Company received funds of
$790,000  and  made  payments  of  $207,000  to  Strategic   Capital   Partners.
Outstanding  amounts  accrue  interest at 5% per year,  matures on December  31,
2014, and can be repaid at any time prior to maturity.

The balance is  recognized  as note payable  related  party in the  accompanying
balance sheet and was $1,408,000 and $825,000 as of March 31, 2015 and September
30, 2014, respectively.  Accrued interest was approximately $8,500 and $5,000 at
March 31, 2015 and September 30, 2014, respectively.

Interest expense related to the related party note payable was $11,199 and $-0-,
$21,061 and $-0-for  the three month and six month  period  ended March 31, 2015
and 2014 respectively.

During the six month period ended March 31, 2015 Strategic Capital Partners paid
expenses  of $37,720 on behalf of the  Company of which the  Company  repaid all
related amounts as of March 31, 2015.


                                       19
<PAGE>



                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 11.    WARRANTS & OPTIONS

Stock option activity is presented below.

                                                          Weighted
                                              Weighted     Average
                                              Average    Contractual   Aggregate
                                 Number of    Exercised     Term       Intrinsic
                                   Shares      Price       (Years)       Value
                                 -----------  ---------  ------------  ---------
Outstanding at September 30,
2014                              1,105,000       9.12             2           -
                                 -----------  ---------  ------------  ---------
Granted                             100,000       4.00             3           -
                                 -----------  ---------  ------------  ---------

Outstanding at March 31, 2015     1,205,000       6.47             2           -
                                 ===========  =========  ============  =========

Expected to vest at
  March 31, 2015                  1,205,000       6.47            -0-        -0-
                                 ===========  =========  ============  =========


Exercisable at March 31, 2015       205,000       4.00            -0-        -0-
                                 ===========  =========  ============  =========

As part of its  amended  agreement  with WGP (see Note 3),  the  Company  issued
options which allow WGP to purchase up to 100,000 shares of the Company's common
stock at a price of $4.00 per share.  The options  were valued at  approximately
$19,000  using  the  Black  Scholes  option  pricing  model  with the  following
assumptions:  $.02 value of stock on grant date;  $4.00 exercise price immediate
vesting;  .75 risk free interest rate; 100% volatility  factor;  and 0% dividend
yield and were recorded as stock based compensation  expense. The options expire
in February 2018.

Total stock based compensation  expense for the three and six month period ended
March 31, 2015 was $184,522 and $297,306.

NOTE 12.    COMMITMENTS AND CONTIGENTCY

Massachusetts Land Purchase

On January 14,  2015,  the Company  entered into an agreement to purchase a 52.6
acre parcel of  undeveloped  land in  Freetown,  Massachusetts.  The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts  Medical Cannabis Center "MMCC". Plans for the
MMCC may include the  construction  of sustainable  greenhouse  cultivation  and
processing  facilities  that  will be  leased  or sold to  Registered  Marijuana
Dispensaries under the Massachusetts Medical Marijuana Program.

                                       20
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
                      six month period ended March 31, 2015

NOTE 12.    COMMITMENTS AND CONTIGENTCY (continued)

Massachusetts Land Purchase

Additional  plans  for the MMCC may  include a testing  laboratory,  a  research
facility,  a  training  center,  an  infused  product  production  facility  and
corporate offices.

The Company paid the seller a refundable $100,000 deposit upon the signing of
the agreement which amount will be applied toward the purchase price of
$4,000,000 at the closing or returned at the option of the Company. The closing
date was moved from June 1, 2015 to September 1, 2015.

In March of 2015 the Company  contracted with Campinelli  Associates  Management
Corp to a assist with the permitting and schematic design for the  Massachusetts
Medical Cannabis  Center.  Campanelli  Associates  Management Corp. will provide
owner's  representation and provide technical and planning support to manage the
schematic design and permitting process.

Campanelli's  fee for this phase of the  project  will be $125,000 to be paid at
the rate of $15,000  per month (to be paid on the 1st of each month) with a lump
sum payment of the balance due at the end of this  Permitting,  Development  and
Schematic  Design  Services  phase.  This phase of the  project  shall be deemed
complete when the land has been purchased and all permits  necessary to commence
construction have been obtained and permit appeal periods have expired.

As part of the agreement,  AmeriCann secured the right to option for purchase an
adjacent  parcel of land owned by  Campinelli  Associates.  After a  preliminary
review,  the site parcel was deemed unusable and the Company waived its right to
the option in April.

NOTE 13    LEASE COMMITMENTS

The Company leases its office space located at 3200 Brighton Boulevard,  Denver,
Colorado for $2,870 per month commencing June 18, 2014 and ending June 30, 2015.
The Company paid a refundable  deposit of $3,110. The lease expense at March 31,
2015 and 2014 was $8,560 and $-0- for three  months and $16,870 and $-0- for the
six month periods respectively.

The Company leases an automobile under an operating lease commencing  October 4,
2014 for 39 months at $611 per month. The lease expense for three and six months
March 31, 2015 and 2014 was $1,834 and $-0- and $4,286 and $-0- respectively. At
March 31, 2015 the future rental payments  required under  operating  leases are
$20,163.

NOTE 14.    SUBSEQUENT EVENTS

As discussed in Note 3, in 2014 the Company  entered into a Loan and  Consulting
Agreement  with  Nature's  Own  Wellness  Center,  LLC,  and 4900  Jackson,  LLC
("4900"),  collectively  "Nature's  Own".  Pursuant to the Loan  Agreement,  the
Company lent  Nature's Own  $1,000,000 on a secured  basis.  The proceeds of the
$1,000,000  were to be used to convert an existing  15,000 square foot warehouse
into a cannabis growing and processing facility.

                                       21
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Financial Statements for the three and
           six month period ended March 31, 2015

NOTE 14.    SUBSEQUENT EVENTS (Continued)

The loan had a 30-month  term and had an annual  interest  rate of 18% which was
payable monthly.  Pursuant to the Consulting Agreement,  Nature's Own was to pay
the Company  $300,000 in  consulting  fees for its  cannabis  operations  over a
30-month period.

On January 1, 2015 the Company  modified the Loan and Consulting  Agreement with
Nature's Own. The modification  eliminated the required  principal  payments for
the months of January through May 2015 and increased the final principal payment
due  December 1, 2016 to  $182,531.  The  Consulting  Agreement  was modified to
extend the term under which  consulting  fees were due by five months to May 31,
2017.

In early May  2015,  Nature's  Own's  interest  in the  growing  and  processing
facility was purchased by 4900 and, 4900 assumed Nature's Own obligations  under
the Loan and Consulting  agreements.  On May 20, 2015, the Company  modified the
Loan  and  Consulting  Agreement  with  4900.  Pursuant  to  the  modified  Loan
Agreement,  4900 made a payment to the Company of  $300,000  on the  outstanding
loan balance of $965,000 and the interest rate on the loan decreased from 18% to
12%. The loan will mature on May 1, 2017. The Consulting  Agreement was modified
such that 4900 will pay the Company  $5,000 per month,  rather than  $10,000 per
month,  until May 31, 2017. The proceeds of the loan will continue to be used to
develop the cannabis growing and processing facility.

On July 31,  2014 the  Company  closed on an all cash  purchase  of a  five-acre
parcel of land located in north central  Denver,  Colorado.  The total  purchase
price for the property  was  $2,250,000.  The  property is  currently  zoned for
cannabis  cultivation and processing by the City and County of Denver. On May 5,
2015 the Company  entered into an agreement to sell the property to an unrelated
party for $2,500,000.

The Company has evaluated  subsequent  events  through the date these  financial
statements  were issued and  determined  that no other  disclosure of subsequent
events is required.

                                       22
<PAGE>

Item 2.  Management's  Discussion  and  Analysis of  Financial  Condition  and
         Results of Operation

BUSINESS AND PLAN OF OPERATION

We were  incorporated  on June 25,  2010  under  the laws of  Delaware.  We were
established as part of the Chapter 11 reorganization  of AP Corporate  Services,
Inc.  ("AP").  Under  AP's  Plan of  Reorganization,  as  confirmed  by the U.S.
Bankruptcy  Court for the Central District of California,  we were  incorporated
to:  (i) hold  any  interest  which AP  retained  in the  development  of an MRI
facility in Nevada;  and (ii) issue  shares of its common  stock to AP's general
unsecured creditors, to its administrative creditors, and to its shareholders in
order to enhance their opportunity to recover from the bankruptcy estate.

Since we lacked the  resources to  effectively  develop an MRI facility in June,
2012,  we decided to promote  medical  tourism  by  providing  information  on a
website for those seeking to travel abroad for healthcare  services.  We planned
to generate revenue by selling  advertising to healthcare  providers and related
businesses including hotels and travel businesses.

In September  2013 we abandoned our business plan relating to promoting  medical
tourism.

Our new business  plan  involves  providing an essential  set of services to the
regulated  cannabis  industry.  The market research firm ArcView Group estimates
the market  for the  regulated  cannabis  industry  for 2013 was $1.53  billion,
expected to grow to $2.53 billion in 2014 and $10.2 billion in ten years.  Based
on the ArcView analysis,  the cannabis industry is projected to grow faster than
any other industry in the country over the next decade.

While the industry is growing  rapidly,  the cannabis  industry  faces two major
obstacles  that  challenge  its growth and  profitability.  The  cultivation  of
cannabis is a very capital-intensive  enterprise. Many cannabis entrepreneurs do
not have access to the capital that is necessary to build the  infrastructure to
meet growing demand.  Traditional  sources of financing,  such as banks, are not
available  currently  to cannabis  producers  and  retailers.  Also,  there is a
significant shortage of knowledge related to virtually all areas of the cannabis
business.  When new states are added to the list of regulated  cannabis markets,
there will be a  scarcity  of  experience  and  expertise  to serve the needs of
growers and retailers in these states.

We believe that, since the industry is so new, there is significant potential to
transform the cannabis  business  through  professionalism,  innovation  and the
application of technology.

We are  based in  Colorado,  which by  virtue  of it being  the  first  state to
implement cannabis access to adults for non-medical purposes,  provides an ideal
environment  for which to serve the  growing  cannabis  industry  as it  expands
nationally.

We do not intend to cultivate, produce, distribute or sell cannabis, but plan to
provide a wide variety of essential  services to  licensed,  regulated  cannabis
growers and retailers.  These services  include  financing,  cultivation  center
design, operational consulting, real estate development, and research.

                                       23
<PAGE>

We  plan  to  generate  revenue  and  profits  from  several  sources  including
developing and selling  cannabis  cultivation  facilities,  interest income from
loans to licensed  cannabis  operators,  consulting and the licensing or sale of
intellectual property.

In January 2014, we began operating in accordance with our new business plan.

On January 17, 2014,  Strategic Capital Partners,  LLC ("SCP") a firm controlled
by Benjamin J. Barton,  acquired  14,950,000  shares of our  outstanding  common
stock from a group of our shareholders.

On  February  21,  2014 we changed our name from  Nevada  Health  Scan,  Inc. to
Americann,  Inc. and  declared a stock  dividend in the amount of four shares of
common stock for each issued and outstanding share of common stock.

On February 24, 2014 SCP returned 65,750,000 of its shares to us.

During  March and April 2014 we sold  1,000,000  shares of our  common  stock to
private investors at a price of $0.75 per share.  Benjamin J. Barton, one of our
officers and directors, purchased 400,000 shares as an investment.

During July 2014 we raised $2,373,000 through a private sale of 791,000 Units at
a price of $3.00 per Unit.  Each Unit consisted of one share of common stock and
one warrant.  Each warrant allows the holder to purchase one share of our common
stock at a price of $8.00  per  share  anytime  on or  before  April  30,  2018.
Benjamin J. Barton purchased 666,667 Units for cash as an investment.

During the summer of 2014 we entered into a Financing and  Consulting  Agreement
with Nature's Own Wellness  Centers,  a licensed  Colorado  cannabis  dispensary
owner and grower.  Pursuant to the agreement, we loaned Nature's Own $1,000,000.
The  proceeds  of the secured  loan will be used by  Nature's  Own to convert an
existing 15,000 square foot warehouse into a new cannabis growing and processing
facility.

The loan has a 30-month  term,  bears  interest at 18%  annually,  and  requires
monthly  payments to us.  Nature's  Own will also pay us $300,000 in  consulting
fees for its cannabis  operations over the 30-month period. Over the term of the
30-month loan, the agreement calls for us to receive average monthly payments of
principal, interest and consulting fees in excess of $56,000.

Effective  January 1, 2015 we modified our loan and  consulting  agreement  with
Natures  Own.  The  modification  to  the  loan  agreement  eliminated  required
principal  payments  for  January  through  May 2015  and  increased  the  final
principal payment due on December 1, 2016 to $182,531.  The consulting agreement
was  modified to extend the term of the  consulting  agreement by five months to
May 31, 2017. Monthly consulting payments of $10,000 remain the same.

On July 31, 2014 we closed on an all cash purchase of a five-acre parcel of land
located in north central  Denver,  Colorado.  The total  purchase  price for the
property  was   $2,250,000.   The  property  is  currently  zoned  for  cannabis
cultivation  and processing by the City and County of Denver.  On May 5, 2015 we
entered  into an  agreement  to sell the  property  to an  unrelated  party  for
$2,500,000.

                                       24
<PAGE>

On September 21, 2014 we entered into two loan  agreements  with Wellness  Group
Pharms,  LLC  ("WGP").  Subsequent  to entering  into the loan  agreements  WGP,
applied  to the  state  of  Illinois  for  licenses  to  operate  two  marijuana
cultivation  facilities under the Illinois Compassionate Use of Medical Cannabis
Pilot Program Act.

On February 2, 2015 WGP was notified that it was awarded one of the two licenses
for which it applied under the Illinois Act. The State only issued a total of 18
cultivation and processing licenses.

Under the terms of the loan agreement  pertaining to the license awarded to WGP,
we had  agreed to loan WGP up to  $4,700,000,  subject  to  certain  conditions.
Proceeds  from the loan would be used to  construct  the  marijuana  cultivation
facility and for start-up costs.

On February 23, 2015 we amended our agreement with WGP.

The amended  agreement called for us to serve as the project developer and owner
of the IMCC, and to provide working capital funding and horticultural assistance
to WGP. As part of the amended  agreement,  we issued options which allow WGP to
purchase up to 100,000 shares of our common stock at a price of $4.00 per share.
The options expire in February 2018.

The amended  agreement  included a Draw  Schedule  by which we were  required to
provide  construction  capital to build the IMCC and provide working capital for
WGP.

We  provided  initial  funding  of  $600,000  to WGP on  February  23,  2015  in
accordance with Draw #1.

The  budgeted  amount  for Draw #2 was  $379,333.  Prior to the  funding of this
amount for Draw #2,  WGP  requested  that we fund an  additional  $214,522,  not
initially  scheduled for Draw #2, for an essential metal building that was to be
delivered earlier than anticipated by WGP. The original Agreement scheduled this
item to be paid from Draw #4. With this request,  WGP agreed to transfer certain
non-essential  items for Draw #2 to future draws to  accommodate  the additional
expense for the building.

We  provided  in excess of  $405,000  for Draw #2,  which  exceeded  the Draw #2
requirements by approximately  $26,000. The total capital we provided after Draw
#2 was in excess of $1,000,000.

On April 7, 2015, WGP sent us notice claiming that the $214,522  payment that we
made for the  building  was not  authorized  by WGP and that our payment for the
building was made "...at its own election."  WGP further  claimed that we failed
to  provide  funding  pursuant  to the  amended  agreement  and as a result  our
agreements with WGP were void.

On April 10, 2015, WGP notified us that our relationship with WGP could continue
only if we agreed to accept significant changes to the original  agreements.  In
this correspondence, WGP made eight demands including the following:

                                       25
<PAGE>

     (1)  That we provide an extra $2,000,000 in working capital to WGP, and

     (2)  That we agree to reduce the interest rate on the working  capital loan
          to WGP by 6%, and

     (3)  That we would not pay vendors and suppliers directly,  but rather that
          all funds had to be provided to WGP for disbursements.

We believe that WGP's notice to void the  agreements  was without merit and that
this was merely an attempt to renegotiate the terms of a valid contract.

We rejected WGP's proposal outright.

We have  notified WGP that we have  fulfilled  our  obligations  pursuant to our
agreements  with WGP but due to  WGP's  anticipatory  breach  of  contract,  and
repeated  lack of good  faith and fair  dealing,  our  agreements  with WGP were
terminated.

We will take all necessary steps to recover our investment and pursue our claims
against WGP.

On January 14, 2015, we entered into an agreement to purchase a 52.6 acre parcel
of  undeveloped  land  in  Freetown,  Massachusetts.  The  property  is  located
approximately  47 miles southeast of Boston.  We plan to develop the property as
the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC may include
the construction of sustainable greenhouse cultivation and processing facilities
that will be  leased  or sold to  Registered  Marijuana  Dispensaries  under the
Massachusetts  Medical  Marijuana  Program.  Additional  plans  for the MMCC may
include a testing laboratory, a research facility, a training center, an infused
product production facility and corporate offices.

We paid the seller  $100,000 upon the signing of the agreement which amount will
be applied toward the purchase  price of $4,000,000 at the closing.  The closing
must take place on or before September 1, 2015.

We  plan to  expand  to  other  states  that  have  approved  and  regulate  the
cultivation and sale of cannabis.

On March 3, 2015 we closed on a $650,000  loan from a third  party.  The Note is
due  September  21,  2015 and secured by our Monaco  Street  property in Denver,
Colorado.  The annual interest rate for the loan is 14%. The loan,  including is
interest, is due on September 21, 2015.

As of March 31, 2015 we had borrowed $1,408,000 from Strategic Capital Partners,
LLC, a Company  controlled  by  Benjamin  J.  Barton,  one of our  officers  and
directors.  The loan is unsecured and bears interest at 5% per year. Interest is
payable on March 31 and  September  30 of each year.  The loan,  plus all unpaid
principal interest, is due on December 31, 2015.

RESULTS OF OPERATIONS

During the three  month  period  ended March 31,  2015 we  generated  $50,000 in
revenue and $54,595 in interest income.  During the six month period ended March
31,  2015 we  generated  $80,000 in revenue and  $100,134  in  interest  income.
However,  for the three and six month  periods  ended March 31, 2014, we did not
generate any revenue. As a result we have little operating history upon which to
evaluate our business.

                                       26
<PAGE>

General and  administrative  expenses for the three month period ended March 31,
2015, were $467,943.  This compares with General and Administrative expenses for
the three month period ended March 31, 2014 of $307,347. The increase in general
and  administrative  expenses  during  the  current  period  was the  result  of
increases  in  contract  and   consulting,   rent,   salaries  and  stock  based
compensation expenses associated with operating the company.

We had a net loss of $(377,590) for the three month period ended March 31, 2015.
This compares with a net loss for the three month period ended March 31, 2014 of
$(242,003). The increase in the net loss during the current period was primarily
the result of the increase in G&A expenses,  partially  offset by an increase in
Revenue and Other Income.

Since the Company was inactive  prior to January  2014,  any  comparison  of the
Company's  operating  results for the three and six months  ended March 31, 2015
and its  financial  condition as of March 31, 2015 with any prior  periods would
not be meaningful.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 2015 we had borrowed $1,408,000 from Strategic Capital Partners,
LLC, a Company  controlled  by  Benjamin  J.  Barton,  one of our  officers  and
directors.  The loan is unsecured and bears interest at 5% per year. Interest is
payable on March 31 and  September  30 of each year.  The loan,  plus all unpaid
principal interest, is due on December 31, 2015.

Our  sources  and (uses) of funds for the six months  ended  March 31,  2015 are
shown below:

      Net cash (used in) operations             $(332,621)
      Website development                         (33,000)
      Deposit on land purchase                   (100,000)
      Advances to WGP                            (937,341)
      Payment received on note receivable          35,000
      Loan from third party                       611,006
      Loan from related party                     790,000
                                                        -
      Payment on loan from related party         (207,000)

We do not have any firm  commitments  from any  person  to  provide  us with any
capital.

See Note 1 to the  financial  statements  included  as part of this report for a
discussion of our significant accounting policies.

As of March 31, 2015 we did not have any off balance sheet arrangements.

                                       27
<PAGE>

Item 4.  Controls and Procedures.

     (a) The Company  maintains a system of controls and procedures  designed to
ensure that  information  required to be disclosed in reports filed or submitted
under the Securities Exchange Act of 1934, as amended ("1934 Act"), is recorded,
processed,  summarized and reported,  within time periods specified in the SEC's
rules and forms and to ensure that  information  required to be disclosed by the
Company  in the  reports  that it files  or  submits  under  the  1934  Act,  is
accumulated  and  communicated  to  the  Company's  management,   including  its
Principal  Executive  and Financial  Officers,  as  appropriate  to allow timely
decisions  regarding  required  disclosure.  As of March 31, 2015, the Company's
Principal  Executive and Financial  Officers  evaluated the effectiveness of the
design and operation of the Company's disclosure controls and procedures.  Based
on that evaluation,  the Principal  Executive and Financial  Officers  concluded
that the Company's  disclosure  controls and procedures  were not effective at a
reasonable  assurance level as a result of a material weakness primarily related
to a lack of a sufficient  number of  personnel  with  appropriate  training and
experience in accounting  principles  generally accepted in the United States of
America,  or GAAP. As a result,  the Company did not adequately test whether its
disclosure  controls and procedures  were operating  sufficiently  to identify a
deficiency,  or  combination  of  deficiencies,  that may result in a reasonable
possibility that a material  misstatement of the financial  statements would not
be prevented or detected on a timely basis.  While the Company's  management has
reviewed the financial  statements and underlying  information  included in this
report on Form 10-Q in detail and believes the procedures performed are adequate
to fairly present,  in all material respects,  the Company's financial position,
results of operations and cash flows for the periods  presented,  the deficiency
in  accounting  personnel  that existed  during the three months ended March 31,
2015 could have led to errors in the financial statements.

     (b) Changes in Internal  Controls.  There were no changes in the  Company's
internal  control over  financial  reporting  during the quarter ended March 31,
2015, that materially  affected,  or are reasonably likely to materially affect,
its internal control over financial reporting.

                                       28
<PAGE>


                           PART II. OTHER INFORMATION

Item 6.  Exhibits

Exhibits

  31.1            Certification  pursuant to Section 302 of the Sarbanes-Oxley
                  Act of 2002.

  31.2            Certification  pursuant to Section 302 of the Sarbanes-Oxley
                  Act of 2002.

  32              Certification  pursuant to Section 906 of the Sarbanes-Oxley
                  Act.





                                       29
<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                      AMERICANN, INC.


June 15, 2015                          By:/s/ Timothy Keogh
                                          ----------------------------------
                                          Timothy Keogh, Principal Executive
                                          Officer





June 15, 2015                          By:/s/ Benjamin Barton
                                          ----------------------------------
                                          Benjamin Barton, Principal
                                          Financial and Accounting Officer